Suchergebnisse - "Jakate, Abhijeet"

PubPharm (9)

1

Atogepant and sumatriptan : no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial

enthalten in: Pain management | 2022

von Boinpally, R. | Jakate, A. | Butler, M. | +1

2

Single-Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment : Results From an Open-Label, Phase 1 Trial

enthalten in: Clinical pharmacology in drug development | 2021

von Boinpally, R. | Jakate, A. | Butler, M. | +2

3

Time course of efficacy of ubrogepant for the acute treatment of migraine : Clinical implications

enthalten in: Cephalalgia : an international journal of headache | 2021

von Goadsby, P. | Blumenfeld, A. | Lipton, R. | +7

4

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine : A randomized phase 1b drug-drug interaction study

enthalten in: Headache | 2021

von Jakate, A. | Blumenfeld, A. | Boinpally, R. | +6

5

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans

enthalten in: Headache | 2020

von Jakate, A. | Boinpally, R. | Butler, M. | +3

6

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

enthalten in: Clinical and translational science | 2020

von Ankrom, W. | Bondiskey, P. | Li, C. | +11

7

Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults : Results From a Randomized Trial

enthalten in: Clinical pharmacology and therapeutics | 2020

von Jakate, A. | Boinpally, R. | Butler, M. | +3

8

Pharmacology and Pharmacokinetics of Ubrogepant : A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine

enthalten in: The Journal of family practice | 2020

von Blumenfeld, A. | Edvinsson, L. | Jakate, A. | +1

9

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing : Randomized, placebo-controlled trial in healthy adults

enthalten in: Cephalalgia : an international journal of headache | 2019

von Goadsby, P. | Tepper, S. | Watkins, P. | +8

1
[1]